Danaher to Present at J.P. Morgan Healthcare Conference
Werte in diesem Artikel
WASHINGTON, Jan. 6, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 14, 2025 at 11:15 a.m. PT. The event will be simultaneously webcast and can be accessed on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations."
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/danaher-to-present-at-jp-morgan-healthcare-conference-302343009.html
SOURCE Danaher Corporation
Ausgewählte Hebelprodukte auf Danaher
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Danaher
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Danaher Corp.
Analysen zu Danaher Corp.
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Danaher Buy | Needham & Company, LLC | |
30.05.2019 | Danaher Outperform | Wolfe Research | |
17.04.2019 | Danaher Buy | Needham & Company, LLC | |
28.02.2019 | Danaher Buy | Needham & Company, LLC | |
03.01.2019 | Danaher Buy | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Danaher Buy | Needham & Company, LLC | |
30.05.2019 | Danaher Outperform | Wolfe Research | |
17.04.2019 | Danaher Buy | Needham & Company, LLC | |
28.02.2019 | Danaher Buy | Needham & Company, LLC | |
03.01.2019 | Danaher Buy | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
21.04.2017 | Danaher Sector Perform | RBC Capital Markets | |
27.05.2016 | Danaher Sector Perform | RBC Capital Markets | |
22.04.2016 | Danaher Sector Perform | RBC Capital Markets | |
27.01.2016 | Danaher Sector Perform | RBC Capital Markets | |
23.10.2015 | Danaher Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
14.12.2006 | Danaher underweight | Prudential Financial |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Danaher Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen